LIFECORE BIOMEDICAL, INC. \DE\ 8-K

What Happened
Lifecore Biomedical, Inc. announced on Form 8-K that its Compensation Committee adopted the Lifecore Biomedical, Inc. Incentive Bonus Plan effective January 14, 2026. The Plan authorizes cash bonus awards for executive officers and certain other employees selected by the Compensation Committee, based on achievement of financial and other performance targets. The 8-K was filed January 16, 2026 and is signed by CFO Ryan D. Lake.

Key Details

• Effective date of the Plan: January 14, 2026.
• Awards: cash payments to participating executive officers and designated employees tied to specified performance targets.
• Compensation Committee powers: designate participants; set performance periods, targets, weights and award amounts; determine payout formulas; and adjust awards for unusual events (e.g., acquisitions/divestitures).
• The full Plan text is filed as Exhibit 10.1 to the 8-K.

Why It Matters
This filing confirms Lifecore’s formal incentive structure for 2026, linking executive and select employee pay to measurable performance goals. For investors, that can affect near-term cash compensation expense and signals how management will be motivated to drive company financial and operational targets; investors should watch future disclosures for specific targets, payout amounts and any actual bonus payments.